Skip to main content

Research Repository

Advanced Search

SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings

Murewanhema, Grant; Dzinamarira, Tafadzwa; Madziva, Roda; Herrera, Helena; Musuka, Godfrey

SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings Thumbnail


Authors

Grant Murewanhema

Tafadzwa Dzinamarira

Helena Herrera

Godfrey Musuka



Citation

Murewanhema, G., Dzinamarira, T., Madziva, R., Herrera, H., & Musuka, G. (2022). SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings. Pharmacoepidemiology and Drug Safety, 31(3), 379-380. https://doi.org/10.1002/pds.5393

Journal Article Type Letter
Acceptance Date Dec 6, 2021
Online Publication Date Dec 26, 2021
Publication Date 2022-03
Deposit Date Jan 4, 2022
Publicly Available Date Dec 27, 2022
Journal Pharmacoepidemiology and Drug Safety
Print ISSN 1053-8569
Electronic ISSN 1099-1557
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 31
Issue 3
Pages 379-380
DOI https://doi.org/10.1002/pds.5393
Keywords Pharmacology (medical); Epidemiology
Public URL https://nottingham-repository.worktribe.com/output/7164338
Publisher URL https://onlinelibrary.wiley.com/doi/10.1002/pds.5393

Files





You might also like



Downloadable Citations